Compare Fubotv Inc (FUBO) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fubotv Inc vs Sana Biotechnology Inc — how do they compare? Fubotv Inc trades at $8.86 (market cap $1.02B), while Sana Biotechnology Inc trades at $2.8 (market cap $836.71M). The key difference: Fubotv Inc is the larger of the two by market cap, and Fubotv Inc is more actively traded (978,631 versus 4,507,444). Which is the better fit depends on your goals — on Pluang, investors hold Fubotv Inc for 35 Days and Sana Biotechnology Inc for 23 Days on average.
| FUBO | SANA | |
|---|---|---|
Market Cap | $1.02B | $836.71M |
Volume | 978,631 | 4,507,444 |
Sector | Media | Health |
52-Week High | $48.96 | $5.92 |
52-Week Low | $8.09 | $2.68 |
Typical Hold Time | 35 Days | 23 Days |
Enterprise Value | $1.19B | $749.96M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUBO trades at $8.84, down 4.43% today, with bearish technical signals from moving averages but neutral oscillators. The company shows improving fundamentals with revenue growth to $1.62B in 2024 and a projected net profit of $123M in 2025. Recent developments include new sports streaming agreements with NHL and TBL Team Boxing League, while analyst consensus remains mixed with 47% buy ratings and a $63.38 price target.
FUBO presents a turnaround story with improving profitability metrics and strategic content partnerships driving growth potential. However, risks include persistent negative cash flow, high debt levels, and intense streaming competition. The stock's current valuation appears attractive with P/E of 2.43 and P/S of 0.19, but execution risks remain significant for investors.
SANA Biotechnology trades at $2.84, up 4.41% today, while showing bearish technical signals with moving averages indicating selling pressure. The company remains pre-revenue with significant losses (-$244.17M net income in 2025) and negative cash flow from operations. Recent investor conference presentations highlight ongoing development of engineered cell therapies, though earnings have missed expectations in two of the last three quarters.
Despite analyst optimism (82% buy ratings), SANA faces substantial execution risk as a clinical-stage biotech with no current revenue and high cash burn. The stock's outlook depends heavily on clinical trial progress and future funding needs, with current valuation at 5.41x book value despite negative profitability metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
